How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Listen now
Description
What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville shares his biggest takeaways, from the importance of founder-market fit to the need to challenge assumptions in a nascent field.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More Episodes
Join Liz Centoni, Chief Customer Experience Officer at Cisco, as she shares her insights on leveraging AI to revolutionize customer experience. Discover how Cisco is utilizing generative AI, machine learning, and co-creation to automate tasks, provide self-service options, and deliver predictive...
Published 06/13/24
The field of aging research is undergoing a revolution, and the Buck Institute is at the forefront of this transformative movement. In this captivating interview, Dr. Eric Verdin shares insights into the groundbreaking discoveries that are redefining our understanding of the aging process. From...
Published 06/11/24
Published 06/11/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
